Noninvasive positive pressure ventilation in acute respiratory failure: Does it improve outcomes?

Department of Pulmonary and Critical Care Medicine, Cleveland Clinic Foundation, OH 44195, USA.
Cleveland Clinic Journal of Medicine (Impact Factor: 2.71). 09/2001; 68(8):677-80. DOI: 10.3949/ccjm.68.8.677
Source: PubMed


Studies have shown that noninvasive positive pressure ventilation (NPPV) is well tolerated and safe, and that it improves oxygenation in some patients with acute respiratory failure. By obviating the need for endotracheal intubation in certain conditions, it results in fewer complications, shorter hospital stays, and consequently, lower mortality rates and costs of care.

Full-text preview

Available from:

  • No preview · Article ·
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The United States is currently in the midst of a heart failure epidemic. This has a tremendous impact on morbidity, mortality, and associated costs to our health care system. With demographic trends expected to double the at-risk cohort over the next 30 years, there is a serious need to develop more efficacious strategies addressing early diagnosis, treatment options, and outcomes in patients stricken with heart failure. This article reviews the newest diagnostics, therapeutics, and strategies for the management of heart failure and suggests appropriate implementation of these approaches in the emergency department observation unit.
    Full-text · Article · Dec 2003 · Progress in Cardiovascular Diseases
  • [Show abstract] [Hide abstract]
    ABSTRACT: Noninvasive positive-pressure ventilation (NPPV) is increasingly being used in the care of patients suffering acute respiratory failure. High-level evidence supports the use of NPPV to treat exacerbation of chronic obstructive pulmonary disease (COPD). NPPV has also been successfully used with selected patients suffering acute hypoxemic respiratory failure and to allow earlier extubation of mechanically ventilated COPD patients. The evidence for NPPV for acute cardiogenic pulmonary edema is inconclusive. With selected patients NPPV decreases the rate of intubation, mortality, and nosocomial pneumonia. Predictors of NPPV failure include greater severity of illness, lower level of consciousness, lower pH, more air leak around the patient-mask interface, greater quantity of secretions, poor initial response to NPPV, and the presence of pneumonia. NPPV obviates intubation in > 50% of appropriately selected patients. Both nasal and oronasal interfaces have been successfully used to apply NPPV, but the oronasal interface is often preferred for acute respiratory failure. Any ventilator and ventilator mode can be used to apply NPPV, but portable pressure ventilators and pressure-support mode are most commonly used. Inhaled bronchodilators can be administered during NPPV, and NPPV can be delivered with helium-oxygen mixture. Institution-specific practice guidelines may be useful to improve NPPV success.
    No preview · Article · Jul 2004 · Respiratory care
Show more